2020
DOI: 10.1155/2020/9510546
|View full text |Cite
|
Sign up to set email alerts
|

Screening of Abdominal Aortic Aneurysm Using Portable Transthoracic Echocardiography among Patients with Acute Coronary Syndrome

Abstract: Background. Abdominal aortic aneurysm (AAA) and acute coronary syndrome (ACS) share common risk factors. Objectives. To assess the abdominal aortic diameter (AAD) among patients with ACS using transthoracic echocardiography (TTE). Methods. Patients with ACS admitted to our intensive cardiac care unit from December 2013 to June 2014 were screened prospectively for AAA via AAD measurement in the subcostal TTE view. AAA was defined as an aneurysm with a transverse diameter of ≥30 mm. Results. Sixty seven patients… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
(21 reference statements)
0
1
0
Order By: Relevance
“…Previous studies have suggested that the 2.5-MHz probe used during routine transthoracic echocardiography (TTE) may be adequate for the detection of AAA with a sensitivity ranging from 91% to 94% using quick-screen programs and the subcostal view [10,11]. It requires an additional time of only 4 ± 1 min in addition to the standard TTE duration [12]. As most patients with significant CAD undergo a TTE when hospitalized in the cardiology department, we aimed to evaluate the feasibility of AAA screening by the cardiologist at bedside…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies have suggested that the 2.5-MHz probe used during routine transthoracic echocardiography (TTE) may be adequate for the detection of AAA with a sensitivity ranging from 91% to 94% using quick-screen programs and the subcostal view [10,11]. It requires an additional time of only 4 ± 1 min in addition to the standard TTE duration [12]. As most patients with significant CAD undergo a TTE when hospitalized in the cardiology department, we aimed to evaluate the feasibility of AAA screening by the cardiologist at bedside…”
Section: Introductionmentioning
confidence: 99%